Yitao Wang Selected Research

huanglian

12/2022	Classical prescription Huanglian Decoction relieves ulcerative colitis via maintaining intestinal barrier integrity and modulating gut microbiota.
3/2021	Tracking evidences of Coptis chinensis for the treatment of inflammatory bowel disease from pharmacological, pharmacokinetic to clinical studies.
1/2021	Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yitao Wang Research Topics

Disease

91	Neoplasms (Cancer) 01/2024 - 05/2008
29	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
26	Inflammation (Inflammations) 01/2024 - 01/2013
16	Colitis 01/2024 - 10/2016
12	Carcinogenesis 06/2023 - 10/2009
12	Neoplasm Metastasis (Metastasis) 05/2023 - 10/2009
12	Lung Neoplasms (Lung Cancer) 03/2022 - 01/2012
11	Ulcerative Colitis 01/2024 - 01/2018
10	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 10/2013
7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2018
6	Liver Diseases (Liver Disease) 01/2024 - 01/2015
6	Obesity 12/2023 - 12/2011
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 05/2008
4	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2024 - 02/2013
4	Liver Neoplasms (Liver Cancer) 01/2018 - 01/2015
3	Triple Negative Breast Neoplasms 04/2024 - 02/2016
3	Wounds and Injuries (Trauma) 02/2024 - 12/2017
3	Body Weight (Weight, Body) 01/2024 - 10/2018
3	Atrophy 01/2024 - 07/2017
3	Carcinoma (Carcinomatosis) 01/2024 - 11/2017
3	Type 2 Diabetes Mellitus (MODY) 11/2023 - 06/2012
3	Fibrosis (Cirrhosis) 10/2023 - 07/2017
3	COVID-19 09/2023 - 01/2020
3	Ischemic Stroke 03/2023 - 01/2021
3	Brain Ischemia (Cerebral Ischemia) 03/2023 - 09/2021
3	Mitochondrial Diseases (Mitochondrial Disease) 05/2022 - 02/2016
3	Migraine Disorders (Migraine) 04/2022 - 01/2021
3	Liver Cirrhosis (Hepatic Cirrhosis) 04/2020 - 01/2018
3	Ovarian Neoplasms (Ovarian Cancer) 05/2017 - 01/2017
2	Hypoxia (Hypoxemia) 04/2024 - 03/2023
2	Human Influenza (Influenza) 04/2023 - 12/2014
2	Chronic Obstructive Pulmonary Disease (COPD) 04/2023 - 01/2014
2	Pneumonia (Pneumonitis) 04/2023 - 01/2020
2	Diarrhea 05/2022 - 08/2020
2	Cerebral Infarction 05/2022 - 09/2021
2	Weight Loss (Weight Reduction) 05/2022 - 03/2019
2	Dysbiosis 05/2022 - 01/2021

Drug/Important Bio-Agent (IBA)

17	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2011
14	CytokinesIBA 10/2023 - 10/2014
11	Dextran SulfateIBA 10/2023 - 10/2016
10	Messenger RNA (mRNA)IBA 04/2024 - 09/2017
10	BerberineIBA 01/2022 - 01/2011
10	MicellesIBA 11/2017 - 09/2014
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2014
7	Therapeutic UsesIBA 01/2024 - 01/2018
6	Antineoplastic Agents (Antineoplastics)IBA 01/2024 - 01/2011
6	SaponinsIBA 10/2023 - 10/2005
6	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
6	gambogic acidIBA 01/2019 - 03/2012
6	Polylactic Acid-Polyglycolic Acid CopolymerIBA 11/2017 - 12/2014
5	Polysaccharides (Glycans)IBA 01/2024 - 01/2011
5	AntioxidantsIBA 12/2023 - 12/2014
5	PolyphenolsIBA 12/2023 - 01/2014
5	CateninsIBA 12/2022 - 08/2014
5	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2020 - 01/2014
4	MicroRNAs (MicroRNA)IBA 04/2024 - 02/2016
4	triptolideIBA 01/2024 - 03/2012
4	Plant ExtractsIBA 02/2022 - 05/2008
4	RNA (Ribonucleic Acid)IBA 01/2022 - 10/2009
4	Transcription Factors (Transcription Factor)IBA 01/2022 - 05/2017
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 09/2017
4	CurcuminIBA 01/2019 - 01/2014
3	Dextrans (Dextran)FDA Link 01/2024 - 01/2022
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2024 - 01/2022
3	Neuroprotective AgentsIBA 03/2023 - 01/2021
3	huanglianIBA 12/2022 - 01/2021
3	LipidsIBA 10/2022 - 01/2017
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2022 - 03/2019
3	ginsenoside Rh2IBA 03/2022 - 01/2019
3	CaspasesIBA 03/2022 - 09/2011
3	Long Noncoding RNAIBA 01/2022 - 01/2018
3	AcidsIBA 01/2022 - 06/2012
3	artemisinin (artemisinine)IBA 08/2021 - 07/2011
3	IntegrinsIBA 01/2021 - 01/2013
3	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2019 - 10/2013
3	CucurbitacinsIBA 01/2019 - 09/2012
3	elemeneIBA 01/2019 - 01/2011
3	tanshinoneIBA 01/2019 - 12/2014
3	Ethanol (Ethyl Alcohol)IBA 01/2018 - 01/2011
3	DisulfidesIBA 01/2017 - 10/2015
3	SurvivinIBA 10/2016 - 06/2015
3	Glycyrrhetinic Acid (Po 12)IBA 01/2016 - 09/2015
2	Tight Junction ProteinsIBA 01/2024 - 09/2021
2	AlkaloidsIBA 12/2023 - 01/2020
2	TeaIBA 12/2023 - 04/2020
2	Blood Glucose (Blood Sugar)IBA 11/2023 - 06/2012
2	InflammasomesIBA 10/2023 - 01/2022
2	BilirubinIBA 10/2023 - 01/2020
2	ginsenoside M1IBA 10/2023 - 01/2019
2	huanglian-jie-du decoctionIBA 03/2023 - 01/2022
2	OccludinIBA 12/2022 - 09/2021
2	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2011
2	SaltsIBA 08/2022 - 01/2021
2	notoginsenoside R1IBA 05/2022 - 09/2021
2	rheinIBA 05/2022 - 01/2022

Therapy/Procedure

42	Therapeutics 01/2024 - 10/2009
16	Drug Therapy (Chemotherapy) 01/2022 - 10/2009
11	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2023 - 03/2012
5	Immunotherapy 01/2022 - 12/2014
3	Oral Administration 10/2023 - 01/2014